×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South Korea Biomaterial Market

ID: MRFR/HC/48462-HCR
200 Pages
Garvit Vyas
February 2026

South Korea Biomaterial Market Research Report By Application (Medical Devices, Tissue Engineering, Drug Delivery, Orthopedics, Wound Care), By Type (Natural Biomaterials, Synthetic Biomaterials, Modified Biomaterials), By Source (Plant-based, Animal-based, Microbial-based) andBy End Use (Healthcare, Pharmaceuticals, Cosmetics) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South Korea Biomaterial Market Infographic
Purchase Options

South Korea Biomaterial Market Summary

As per Market Research Future analysis, the South Korea biomaterial market Size was estimated at 2500.0 USD Million in 2024. The South Korea biomaterial market is projected to grow from 2662.5 USD Million in 2025 to 5000.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The South Korea biomaterial market is experiencing robust growth driven by sustainability and innovation.

  • Sustainable packaging solutions are gaining traction as consumers increasingly prefer eco-friendly products.
  • Advancements in material science are enhancing the performance and applicability of biomaterials across various sectors.
  • The healthcare segment is the largest, while the packaging segment is the fastest-growing in the South Korea biomaterial market.
  • Rising demand for eco-friendly products and regulatory support for sustainable practices are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 2500.0 (USD Million)
2035 Market Size 5000.0 (USD Million)
CAGR (2025 - 2035) 6.5%

Major Players

BASF SE (DE), DuPont de Nemours Inc (US), Covestro AG (DE), Mitsubishi Chemical Corporation (JP), Evonik Industries AG (DE), NatureWorks LLC (US), 3M Company (US), Futerro (BE)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

South Korea Biomaterial Market Trends

The biomaterial market in South Korea is currently experiencing a notable transformation, driven by increasing environmental awareness and the demand for sustainable alternatives to traditional materials. This shift is largely influenced by government initiatives aimed at promoting eco-friendly practices and reducing reliance on fossil fuels. As a result, various industries, including packaging, automotive, and healthcare, are increasingly adopting biomaterials to meet regulatory requirements and consumer preferences. The emphasis on innovation in material science is also propelling the development of advanced biomaterials that offer enhanced performance and functionality. In addition, the South Korean government is actively supporting research and development in the biomaterial sector, which is likely to foster collaboration between academia and industry. This collaborative approach may lead to the emergence of new applications and technologies that could further expand the biomaterial market. Moreover, the growing trend of circular economy practices is encouraging companies to explore biodegradable and compostable materials, thereby reducing waste and promoting sustainability. Overall, the biomaterial market in South Korea appears poised for growth, driven by a combination of regulatory support, consumer demand, and technological advancements.

Sustainable Packaging Solutions

The demand for sustainable packaging solutions is rising within the biomaterial market. Companies are increasingly seeking biodegradable and compostable materials to reduce environmental impact. This trend aligns with consumer preferences for eco-friendly products, prompting manufacturers to innovate and develop new packaging options that meet sustainability criteria.

Advancements in Material Science

Innovations in material science are significantly influencing the biomaterial market. Research institutions and companies are collaborating to create advanced biomaterials with improved properties. These developments may lead to enhanced performance in various applications, including medical devices and construction materials, thereby expanding market opportunities.

Government Support and Regulation

Government initiatives and regulations are playing a crucial role in shaping the biomaterial market. Policies promoting the use of sustainable materials and providing funding for research are encouraging industry growth. This support may facilitate the transition towards more environmentally friendly practices across multiple sectors.

South Korea Biomaterial Market Drivers

Growing Applications in Healthcare

The healthcare sector is increasingly adopting biomaterials for various applications, which is propelling the growth of the biomaterial market. In South Korea, the demand for biocompatible materials for medical devices, implants, and drug delivery systems is on the rise. This trend is driven by the need for safer and more effective medical solutions. The biomaterial market in healthcare is projected to grow significantly, with estimates suggesting a value of over $800 million by 2027. The integration of biomaterials in regenerative medicine and tissue engineering is particularly noteworthy, as it opens new avenues for treatment and recovery. Consequently, the healthcare industry's reliance on biomaterials is likely to enhance the overall market dynamics.

Rising Demand for Eco-Friendly Products

The increasing consumer awareness regarding environmental sustainability is driving the demand for eco-friendly products in the biomaterial market. In South Korea, consumers are becoming more conscious of the ecological impact of their purchases, leading to a shift towards biodegradable and renewable materials. This trend is reflected in the growth of the biomaterial market, which is projected to reach approximately $1.5 billion by 2026. Companies are responding by innovating and developing new biomaterials that align with consumer preferences for sustainability. This shift not only enhances brand loyalty but also positions companies favorably in a competitive market. As a result, the biomaterial market is likely to experience robust growth fueled by this rising demand for environmentally friendly alternatives.

Technological Innovations in Biomaterials

Technological advancements play a crucial role in shaping the biomaterial market in South Korea. Innovations in material science, such as the development of new biopolymers and composites, are enhancing the performance and applicability of biomaterials across various industries. For instance, the integration of nanotechnology in biomaterials is leading to improved mechanical properties and functionality. The South Korean biomaterial market is expected to witness a compound annual growth rate (CAGR) of around 12% over the next five years, driven by these technological innovations. Companies investing in research and development are likely to gain a competitive edge, as they can offer superior products that meet the evolving needs of consumers and industries alike.

Regulatory Support for Sustainable Practices

Regulatory frameworks in South Korea are increasingly favoring sustainable practices, which is positively impacting the biomaterial market. The government is implementing policies that encourage the use of biodegradable materials and reduce reliance on conventional plastics. These regulations are designed to promote environmental sustainability and align with global trends towards greener alternatives. As a result, companies in the biomaterial market are adapting their strategies to comply with these regulations while also capitalizing on the opportunities they present. The anticipated growth in the biomaterial market is likely to be bolstered by these supportive regulatory measures, which aim to foster innovation and sustainability in material usage.

Increased Investment in Research and Development

Investment in research and development (R&D) is a significant driver of growth in the biomaterial market. In South Korea, both public and private sectors are allocating substantial funds to explore new biomaterials and their applications. This focus on R&D is essential for fostering innovation and enhancing the competitiveness of the biomaterial market. For instance, government initiatives have been established to support startups and established companies in developing advanced biomaterials. The South Korean government has earmarked approximately $200 million for R&D in sustainable materials over the next few years. Such investments are likely to accelerate the pace of innovation and contribute to the overall expansion of the biomaterial market.

Market Segment Insights

By Application: Medical Devices (Largest) vs. Tissue Engineering (Fastest-Growing)

The application segment of the South Korea biomaterial market is dominated by Medical Devices, which hold the largest share, thanks to the escalating demand for advanced medical technologies. Following closely is Tissue Engineering, reflecting significant growth potential as biocompatibility and regenerative capabilities become increasingly valuable in medical applications. Other applications such as Drug Delivery, Orthopedics, and Wound Care are also gaining traction, contributing to the diversity of the market offerings. Growth trends in the South Korea biomaterial market point towards a rising investment in healthcare innovations, with a strong emphasis on personalized medicine and minimally invasive procedures. The demand for effective Drug Delivery systems and regenerative approaches such as those offered by Tissue Engineering is anticipated to surge as the population ages and the prevalence of chronic diseases rises. Furthermore, technological advancements and an increase in healthcare expenditure are propelling the development and adoption of novel biomaterials in the medical field.

Medical Devices (Dominant) vs. Tissue Engineering (Emerging)

Medical Devices are crucial elements in the healthcare landscape, characterized by their reliability, efficacy, and extensive usage in diagnostics and therapeutic applications. This segment benefits from established manufacturing processes and regulatory frameworks, allowing for steady market positioning. In contrast, Tissue Engineering represents an emerging avenue with rapid advancements in regenerative medicine. This approach is defined by the innovation in creating functional tissues from biomaterials, driven by the need for alternatives to traditional surgical methods. Both segments are essential, yet Medical Devices maintain a dominant status due to their established infrastructure, while Tissue Engineering captures attention for its potential to revolutionize treatment modalities.

By Type: Natural Biomaterials (Largest) vs. Synthetic Biomaterials (Fastest-Growing)

In the South Korea biomaterial market, the distribution of market share reveals that Natural Biomaterials currently hold the largest segment, appealing to eco-conscious consumers and industries seeking sustainable alternatives. On the other hand, Synthetic Biomaterials are emerging as a significant player, gaining traction due to their versatility and tailored properties, thereby securing a considerable share of the market. Growth trends indicate a shifting preference towards bio-based and sustainable solutions within the industry. The increasing demand for environmentally friendly products and technological advancements in material science are driving the uptick in Synthetic Biomaterials, marking them as the fastest-growing segment. Innovations in production techniques and formulations are further accelerating growth, making this segment particularly attractive to investors and manufacturers.

Natural Biomaterials (Dominant) vs. Synthetic Biomaterials (Emerging)

Natural Biomaterials are recognized for their eco-friendly characteristics and biodegradability, positioning them as a dominant choice in various applications, including packaging and medical devices. Their ability to reduce environmental impact aligns well with consumer preferences, leading to enhanced market visibility. Conversely, Synthetic Biomaterials present an emerging opportunity, offering customized properties that meet specific requirements across diverse sectors. The adaptability and properties of synthetic options drive innovation, appealing to industries ranging from automotive to healthcare. Together, these segments illustrate the dynamic nature of the South Korea biomaterial market, highlighting a dual approach to sustainability and performance.

By Source: Plant-based (Largest) vs. Microbial-based (Fastest-Growing)

In the South Korea biomaterial market, the plant-based segment holds the largest market share, demonstrating widespread acceptance driven by consumer preferences for sustainable and environmentally friendly alternatives. In contrast, the animal-based segment has seen a decline in favor of plant-based options, while microbial-based materials are gaining traction due to their innovative production processes. Growth trends in this segment are largely influenced by increasing awareness of climate change, leading to heightened demand for eco-friendly products. The governmental policies promoting renewable sources further bolster the microbial-based segment's expansion. Additionally, advancements in biotechnologies create new opportunities, making microbial-based biomaterials more versatile and appealing to various industries, thereby positioning them as the fastest-growing category in this market.

Plant-based (Dominant) vs. Animal-based (Emerging)

The plant-based biomaterials are currently the dominant force in the market, characterized by a robust supply chain and widespread applications ranging from packaging to healthcare. Their sustainability credentials resonate with environmentally conscious consumers and manufacturers alike. In contrast, the animal-based segment is considered emerging, reflecting a shift as consumers and industries pivot towards sourcing materials that prioritize sustainability. While still valuable, this segment faces challenges in public perception and regulatory scrutiny, hence it is essential for companies to innovate and demonstrate ethical sourcing to capitalize on upcoming market opportunities.

By End-use: Healthcare (Largest) vs. Pharmaceuticals (Fastest-Growing)

In the South Korea biomaterial market, the healthcare segment holds the largest market share, driven by the increasing demand for advanced medical treatments and the rising awareness of biocompatibility in medical devices. This segment is followed by pharmaceuticals, which is also witnessing significant growth due to the surge in biopharmaceutical research and the development of innovative therapies that utilize biomaterials. The growth trends in these segments are influenced by several factors, including technological advancements in biomaterials, regulatory support for biocompatible products, and increasing investments in healthcare infrastructure. The pharmaceuticals segment is particularly noteworthy as it seeks to leverage biomaterials for drug delivery solutions, thus positioning itself as the fastest-growing area. The healthcare sector is expected to continue its dominance, whereas the pharmaceutical segment is projected to expand rapidly as new applications emerge.

Healthcare: Dominant vs. Pharmaceuticals: Emerging

The healthcare segment in the South Korea biomaterial market is characterized by its robust demand for implantable devices, regenerative medicine, and wound healing solutions. This segment enjoys the dominant position due to the aging population and growing healthcare expenditures, which compel hospitals and clinics to adopt advanced biomaterials for improved patient outcomes. Conversely, the pharmaceuticals segment, while currently emerging, is rapidly gaining traction through advancements in drug development, particularly in areas like targeted therapy and personalized medicine. The increasing collaboration between biotech firms and research institutions is expected to bolster the use of biomaterials, thereby enhancing the pharmaceutical segment’s growth and market relevance.

Get more detailed insights about South Korea Biomaterial Market

Key Players and Competitive Insights

The biomaterial market in South Korea is characterized by a dynamic competitive landscape, driven by increasing demand for sustainable materials and innovative applications across various industries. Key players such as BASF SE (DE), DuPont de Nemours Inc (US), and Covestro AG (DE) are strategically positioned to leverage their extensive research and development capabilities. These companies focus on innovation and sustainability, which are critical in shaping the competitive environment. Their operational strategies often include partnerships and collaborations aimed at enhancing product offerings and expanding market reach, thereby fostering a more competitive atmosphere.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. This approach is particularly relevant in a moderately fragmented market where several players vie for market share. The collective influence of major companies like Mitsubishi Chemical Corporation (JP) and Evonik Industries AG (DE) contributes to a competitive structure that encourages innovation while also addressing regional market needs.

In October BASF SE (DE) announced a partnership with a local South Korean firm to develop biodegradable plastics tailored for the Asian market. This strategic move underscores BASF's commitment to sustainability and its intent to capitalize on the growing demand for eco-friendly materials in the region. By aligning with local expertise, BASF aims to enhance its product development capabilities and strengthen its market position.

In September DuPont de Nemours Inc (US) launched a new line of biopolymers designed for use in the automotive sector, emphasizing lightweight and sustainable materials. This initiative reflects DuPont's focus on innovation and its strategy to penetrate high-growth sectors. The introduction of these biopolymers is likely to attract automotive manufacturers seeking to meet stringent environmental regulations while enhancing performance.

In August Covestro AG (DE) expanded its production capacity for bio-based polycarbonate materials in South Korea. This expansion is indicative of Covestro's strategy to meet the rising demand for sustainable materials in various applications, including electronics and automotive. By increasing production capacity, Covestro positions itself to capture a larger share of the market while reinforcing its commitment to sustainability.

As of November current trends in the biomaterial market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and collaboration. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident. Companies are likely to differentiate themselves through innovative solutions and sustainable practices, which will be crucial for maintaining a competitive edge in the evolving market.

Key Companies in the South Korea Biomaterial Market include

Industry Developments

In recent months, the South Korea Biomaterial Market has seen notable developments, particularly with companies like SK Innovation and LG Chem enhancing their commitment to sustainable materials. The South Korean government is actively supporting green technologies, leading to increased funding for Research and Development initiatives in biomaterials. In September 2023, Toray Industries announced advancements in biodegradable polymers, furthering the country's efforts towards eco-friendly solutions. Mergers and acquisitions have been significant, with BASF completing the acquisition of a minority stake in a local biocomposite project in August 2023, indicating a growing interest in sustainable materials.

Additionally, SABIC has expanded its bio-based product offerings in South Korea, boosting market presence. Over the last couple of years, demand for bio-based plastics has surged, spurred by increasing environmental regulations and consumer awareness, with companies like Hanwha Solutions investing heavily to expand production capacity. Asahi Kasei's focus on innovative biomaterials has also positioned it favorably in the market. Overall, the South Korean Biomaterial Market is experiencing notable growth, driven by technological innovations and strategic partnerships, reflecting a broad shift towards sustainability within the industry.

Future Outlook

South Korea Biomaterial Market Future Outlook

The Biomaterial Market in South Korea is projected to grow at a 6.5% CAGR from 2025 to 2035, driven by advancements in sustainable materials and increasing healthcare applications.

New opportunities lie in:

  • Development of biodegradable packaging solutions for consumer goods.
  • Investment in R&D for innovative medical implants using biomaterials.
  • Expansion of biocomposite materials in construction for eco-friendly building solutions.

By 2035, the biomaterial market is expected to achieve substantial growth and innovation.

Market Segmentation

South Korea Biomaterial Market Type Outlook

  • Natural Biomaterials
  • Synthetic Biomaterials
  • Modified Biomaterials

South Korea Biomaterial Market Source Outlook

  • Plant-based
  • Animal-based
  • Microbial-based

South Korea Biomaterial Market End-use Outlook

  • Healthcare
  • Pharmaceuticals
  • Cosmetics

South Korea Biomaterial Market Application Outlook

  • Medical Devices
  • Tissue Engineering
  • Drug Delivery
  • Orthopedics
  • Wound Care

Report Scope

MARKET SIZE 2024 2500.0(USD Million)
MARKET SIZE 2025 2662.5(USD Million)
MARKET SIZE 2035 5000.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 6.5% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled BASF SE (DE), DuPont de Nemours Inc (US), Covestro AG (DE), Mitsubishi Chemical Corporation (JP), Evonik Industries AG (DE), NatureWorks LLC (US), 3M Company (US), Futerro (BE)
Segments Covered Application, Type, Source, End-use
Key Market Opportunities Growing demand for sustainable packaging solutions drives innovation in the biomaterial market.
Key Market Dynamics Rising demand for sustainable materials drives innovation and competition in the biomaterial market.
Countries Covered South Korea
Leave a Comment

FAQs

What is the expected market size of the South Korea Biomaterial Market in 2024?

The South Korea Biomaterial Market is expected to be valued at 1.55 billion USD in 2024.

What is the projected market size of the South Korea Biomaterial Market by 2035?

By 2035, the South Korea Biomaterial Market is projected to reach a value of 3.1 billion USD.

What is the expected compound annual growth rate (CAGR) for the South Korea Biomaterial Market from 2025 to 2035?

The South Korea Biomaterial Market is expected to grow at a CAGR of 6.504% from 2025 to 2035.

Which application segment holds the largest market share in the South Korea Biomaterial Market?

The Medical Devices segment holds the largest market share, valued at 0.62 billion USD in 2024.

What is the market value for Tissue Engineering in the South Korea Biomaterial Market in 2024?

The Tissue Engineering segment is valued at 0.35 billion USD in 2024 within the South Korea Biomaterial Market.

Who are the key players in the South Korea Biomaterial Market?

Major players include SK Innovation, Hanwha Solutions, and BASF among others.

What is the expected market value for Drug Delivery by 2035 in the South Korea Biomaterial Market?

The Drug Delivery segment is expected to be valued at 0.55 billion USD by 2035.

What growth opportunities are present in the South Korea Biomaterial Market?

There are significant growth opportunities in medical devices and tissue engineering applications.

How is the South Korea Biomaterial Market expected to evolve by 2035?

By 2035, the Biomaterial Market in South Korea is anticipated to significantly expand, driven by advancements in technology and growing demand.

What is the projected value of the Wound Care segment in the South Korea Biomaterial Market in 2035?

The Wound Care segment is projected to be valued at 0.18 billion USD in 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions